Cerevel Therapeutics Holdings, Inc. Current Ratio 2021-2024 | CERE
Cerevel Therapeutics Holdings, Inc. current ratio from 2021 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-03-31 | $0.86B | $0.08B | 10.22 |
| 2023-12-31 | $1.01B | $0.09B | 10.92 |
| 2023-09-30 | $0.69B | $0.08B | 8.72 |
| 2023-06-30 | $0.75B | $0.07B | 11.47 |
| 2023-03-31 | $0.84B | $0.06B | 13.36 |
| 2022-12-31 | $0.91B | $0.07B | 12.48 |
| 2022-09-30 | $1.00B | $0.06B | 16.64 |
| 2022-06-30 | $0.54B | $0.06B | 9.52 |
| 2022-03-31 | $0.55B | $0.04B | 15.67 |
| 2021-12-31 | $0.58B | $0.04B | 13.59 |
| 2021-09-30 | $0.68B | $0.03B | 21.92 |
| 2021-06-30 | $0.33B | $0.03B | 11.34 |
| 2021-03-31 | $0.35B | $0.03B | 10.24 |
| 2020-12-31 | $0.39B | $0.03B | 13.22 |
| 2020-09-30 | $0.00B | $0.00B | 0.35 |
| 2020-06-30 | $0.00B | $0.00B | 4.02 |
| 2020-03-31 | $0.00B | 0.00 | |
